📊 EMN Key Takeaways
Is Eastman Chemical Co (EMN) a Good Investment?
Despite exceptional revenue growth of 4,307%, Eastman Chemical is burning cash operationally (-$137M) and free cash flow is severely negative (-$240M), indicating fundamental operational distress or integration issues. The company's abysmal return metrics (1.8% ROE, 0.7% ROA) and declining EPS despite revenue surge signal that growth is not translating to shareholder value creation.
Eastman Chemical shows a fundamentally stable but not clearly accelerating profile: cash generation remains positive, leverage is manageable, and liquidity is adequate for a capital-intensive chemicals business. However, profitability is only moderate, free cash flow conversion is not especially strong, and the combination of flat net income with a steep diluted EPS decline suggests weaker growth quality and possible capital allocation or share-count effects that need monitoring.
Why Buy Eastman Chemical Co Stock? EMN Key Strengths
- Substantial asset base of $15.2B provides operational capacity
- Moderate leverage at 0.74x debt-to-equity maintains financial flexibility
- Current ratio of 1.47x indicates adequate near-term solvency
- Positive operating cash flow of $970M and free cash flow of $424M support internal funding capacity
- Balance sheet leverage appears manageable with debt/equity of 0.70x and a current ratio of 1.37x
- Solid gross profitability at 21.1% indicates the business retains some pricing power and product mix resilience
EMN Stock Risks: Eastman Chemical Co Investment Risks
- Negative free cash flow of -$240M (FCF margin -11%) is unsustainable and threatens debt service capability
- Negative operating cash flow of -$137M despite $2.2B revenue indicates severe operational inefficiency or integration distress
- Extremely low returns: 1.8% ROE and 0.7% ROA demonstrate value destruction and poor capital allocation
- EPS declined 46.5% YoY while revenue surged 4,307%, signaling deteriorating earnings quality and one-time revenue event
- Quick ratio of 0.71x combined with negative operating cash flow creates liquidity vulnerability
- Operating and net margins of 6.5% and 5.4% are modest for a cyclical chemicals business and leave limited cushion if demand weakens
- Diluted EPS fell 46.5% year over year despite nearly flat net income, raising concerns about earnings quality and per-share value creation
- Quick ratio of 0.63x and relatively low cash of $566M versus $4.20B long-term debt reduce financial flexibility in a downturn
Key Metrics to Watch
- Operating cash flow - must return to positive to validate sustainability
- Free cash flow and working capital trends - cash burn is the critical bottleneck
- Return on equity trajectory - 1.8% is unacceptable and must improve significantly
- Debt service coverage and interest expense burden given negative operating cash flow
- Operating margin and free cash flow margin
- Diluted EPS trend versus net income trend
Eastman Chemical Co (EMN) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Eastman Chemical Co presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
EMN Profit Margin, ROE & Profitability Analysis
EMN vs Market Sector: How Eastman Chemical Co Compares
How Eastman Chemical Co compares to Market sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Eastman Chemical Co Stock Overvalued? EMN Valuation Analysis 2026
Based on fundamental analysis, Eastman Chemical Co shows some fundamental concerns relative to the Market sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Eastman Chemical Co Balance Sheet: EMN Debt, Cash & Liquidity
EMN Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Eastman Chemical Co's revenue has declined by 10% over the 5-year period, indicating business contraction. The most recent EPS of $7.49 reflects profitable operations.
EMN Revenue Growth, EPS Growth & YoY Performance
EMN Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $2.2B | $107.0M | $0.93 |
| Q3 2025 | $2.2B | $47.0M | $0.40 |
| Q2 2025 | $2.3B | $140.0M | $1.20 |
| Q1 2025 | $2.3B | $165.0M | $1.39 |
| Q3 2024 | $2.3B | $178.0M | $1.49 |
| Q2 2024 | $2.3B | $230.0M | $1.94 |
| Q1 2024 | $2.3B | $134.0M | $1.12 |
| Q3 2023 | $2.3B | $178.0M | $1.49 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Eastman Chemical Co Dividends, Buybacks & Capital Allocation
EMN SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Eastman Chemical Co (CIK: 0000915389)
📋 Recent SEC Filings
❓ Frequently Asked Questions about EMN
What is the AI rating for EMN?
Eastman Chemical Co (EMN) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (HOLD) with 80% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are EMN's key strengths?
Claude: Substantial asset base of $15.2B provides operational capacity. Moderate leverage at 0.74x debt-to-equity maintains financial flexibility. ChatGPT: Positive operating cash flow of $970M and free cash flow of $424M support internal funding capacity. Balance sheet leverage appears manageable with debt/equity of 0.70x and a current ratio of 1.37x.
What are the risks of investing in EMN?
Claude: Negative free cash flow of -$240M (FCF margin -11%) is unsustainable and threatens debt service capability. Negative operating cash flow of -$137M despite $2.2B revenue indicates severe operational inefficiency or integration distress. ChatGPT: Operating and net margins of 6.5% and 5.4% are modest for a cyclical chemicals business and leave limited cushion if demand weakens. Diluted EPS fell 46.5% year over year despite nearly flat net income, raising concerns about earnings quality and per-share value creation.
What is EMN's revenue and growth?
Eastman Chemical Co reported revenue of $2.2B.
Does EMN pay dividends?
Eastman Chemical Co pays dividends, with $96.0M distributed to shareholders in the trailing twelve months.
Where can I find EMN SEC filings?
Official SEC filings for Eastman Chemical Co (CIK: 0000915389) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is EMN's EPS?
Eastman Chemical Co has a diluted EPS of $0.93.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is EMN a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Eastman Chemical Co has a SELL rating with 80% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is EMN stock overvalued or undervalued?
Valuation metrics for EMN: ROE of 1.8% (sector avg: 15%), net margin of 4.9% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy EMN stock in 2026?
Our dual AI analysis gives Eastman Chemical Co a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is EMN's free cash flow?
Eastman Chemical Co's operating cash flow is $-137.0M, with capital expenditures of $103.0M. FCF margin is -11.0%.
How does EMN compare to other Market stocks?
Vs Default sector averages: Net margin 4.9% (avg: 12%), ROE 1.8% (avg: 15%), current ratio 1.47 (avg: 1.8).